Back
CBS PREMIUM ACCESS

A novel receptor-interacting protein-1 (RIP1) inhibitor (547) protects human cardiac cells from ischemia/reperfusion-triggered necroptotic cell death

Session: Poster Session 1
Topic: Ischaemia, Infarction, Cardioprotection
Speaker: Doctor M. Peters (Utrecht, NL)
Event: Frontiers in CardioVascular Biomedicine 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Marijn Peters

University Medical Center Utrecht, Utrecht (Netherlands (The))
0 follower

73 more presentations in this session

Inflammatory mediators to predict left adverse ventricular remodelling in revascularized STEMI patients

Speaker: Miss E. Bevilacqua (Seville, ES)

Access
Abstract
Like
Thumbnail

Silent myocardial infarction in non-insulin dependent type 2 diabetes mellitus patients with low adherence to blood glucose monitoring

Speaker: Doctor K. Viligorska (Chernivtsi, UA)

Access
Abstract
Like
Thumbnail

Implication of caveolae in the pathophysiology of human acute myocardial infarction: a histological study

Speaker: Mr C. Rios Navarro (Valencia, ES)

Access
Abstract
Like
Thumbnail

Ang 1-7 mitigates the thapsigargin induced lowered myocardium tolerance to ischemia and reperfusion

Speaker: Associate Professor L. Tacu (Chisinau, MD)

Access
Abstract
Like
Thumbnail

Searching for cardioprotective microRNA families by bioinformatics analysis of cross-species transcriptomic datasets

Speaker: Doctor B. Agg (Budapest, HU)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 1

Speakers: Doctor M. Peters, Miss E. Bevilacqua, Doctor K. Viligorska, Mr C. Rios Navarro, Associate Professor L. Tacu...
Access
Like
Thumbnail

About the event

Image

Frontiers in CardioVascular Biomedicine 2022

29 April - 1 May 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources